Related Experiment Video
Updated: Apr 26, 2026

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
Published on: October 9, 2016
Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease
Sarah E Flanagan1, Emma Haapaniemi2,3, Mark A Russell1
1Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, EX2 5DW, UK.
Abstract:
Monogenic causes of autoimmunity provide key insights into the complex regulation of the immune system. We report a new monogenic cause of autoimmunity resulting from de novo germline activating STAT3 mutations in five individuals with a spectrum of early-onset autoimmune disease, including type 1 diabetes. These findings emphasize the critical role of STAT3 in autoimmune disease and contrast with the germline inactivating STAT3 mutations that result in hyper IgE syndrome.
Insights
New research identifies de novo germline activating STAT3 mutations as a monogenic cause of early-onset autoimmune diseases, including type 1 diabetes. This contrasts with inactivating mutations linked to hyper IgE syndrome, highlighting STAT3
Area of Science:
- Immunology
- Genetics
- Endocrinology
Background:
- Monogenic causes of autoimmunity offer critical insights into immune system regulation.
- Signal transducer and activator of transcription 3 (STAT3) is crucial in immune responses.
Purpose of the Study:
- To identify novel monogenic causes of autoimmunity.
- To investigate the role of STAT3 in early-onset autoimmune diseases.
Main Methods:
- Genetic analysis of five individuals with early-onset autoimmune disease.
- Characterization of de novo germline STAT3 mutations.
Main Results:
- Identified activating STAT3 mutations as a new monogenic cause of autoimmunity.
- Observed a spectrum of early-onset autoimmune conditions, including type 1 diabetes.
- Demonstrated that activating STAT3 mutations lead to autoimmune disease, contrasting with inactivating mutations causing hyper IgE syndrome.
Conclusions:
- Activating STAT3 mutations represent a novel monogenic cause of early-onset autoimmune disease.
- STAT3 plays a critical and dual role in autoimmune pathogenesis.
- Findings expand understanding of immune dysregulation in monogenic autoimmune disorders.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
Inflammatory Bowel Disease III: Crohn's Disease
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

